Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 2

first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Relationship between social media addiction and bodyweight

100%
Tatar S., Özdemir A., Altuntaş Z. S., Mercimekçi S., Aypak C.
European Journal of Clinical and Experimental Medicine
|
2023
|
issue 1
14-18
EN
Introduction and aim. Social media addiction is increasing rapidly due to the widespread use of smartphones and the availability of the internet. Also, social media addiction constitutes a risk factor for many physical and mental diseases. We aimed to determine the frequency of social media addiction among obese patients. Material and methods. Adult patients who were admitted to the Diet Clinic of a tertiary healthcare hospital in order to lose weight enrolled in the study. A questionnaire including; Social Media Addiction Scale, body mass index (BMI), and demographic information (age, sex) was applied to all participants. Participants were grouped as obese, overweight, and normal weight. Results. A total of 179 patients (mean age: 34.1±12.6 years) enrolled in the study. No difference in sex was found (45.2% women, 47.3% men). Approximately half of the study population was found to be social media addicts. Participants younger than 45 years of age were found to have higher rates of social media addiction (X2 = 4.26; p<0.05). The frequency of social media addiction was found to increase with increasing BMI (41.7%, 43.6%, and 48%; respectively). Conclusion. Social media addiction is prevalent and it is also more frequent in younger adults. Learning more about social media addiction and its relationship with obesity can decrease its health consequence.
2
Publication available in full text mode
Content available

Antiviral drug resistance rates among patients with chronic hepatitis B infection

86%
Özlük S., Bayram Y., Özkaçmaz A., Parlak M., Özdemir A., Aypak C.
European Journal of Clinical and Experimental Medicine
|
2023
|
issue 2
283-288
EN
Introduction and aim. Chronic hepatitis B infection (CHB) affects millions of people around the world. Many clinicians find it challenging to choose therapeutic agents due to the mutations that occur in the hepatitis B virus (HBV) that cause drug resistance. Thus, the aim of this study was to determine the HBV resistance rates against the currently recommended first-line therapies in the region of our country where HBV prevalence is high. Material and methods. A total of 96 patients (56 men and 40 women) with HBV infection were enrolled in the study. The serum samples collected from those were analyzed with real-time polymerase chain reaction analysis followed by pyrosequencing (PyroStar HBV Drug Resistance Test, Altona Diagnostics, Germany) for drug resistance mutations associated with lamivudine, adefovir, telbivudine, entecavir, and tenofovir. Results. HBV drug-resistance mutations were investigated in 80 treatment-naïve and 16 treatment-experienced patients (6 entecavir, 4 PEGylated-interferon, 4 tenofovir, 2 lamivudine). None of the HBV-DNA samples had mutations cause to drug resistance were detected in any codons regions that were analyzed. Conclusion. Antiviral resistance poses serious obstacles for clinicians in the treatment of CHB. Determining whether antiviral resistance exists in HBV is critical to choose the appropriate treatment agent.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.